These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 10436416)

  • 1. Effect of estrogen and antiestrogen therapy in rats bearing mesenchymal tumors.
    Remedi MM; Demarchi M; Hliba E; Depiante-Depaoli M
    Tumour Biol; 1999; 20(5):242-50. PubMed ID: 10436416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocrine and antitumor effects of combined treatment with an antiprogestin and antiestrogen or luteinizing hormone-releasing hormone agonist in female rats bearing mammary tumors.
    Bakker GH; Setyono-Han B; Portengen H; De Jong FH; Foekens JA; Klijn JG
    Endocrinology; 1989 Sep; 125(3):1593-8. PubMed ID: 2527151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble low-molecular-mass tumor-associated antigens promote the suppression of rat mammary tumors by tamoxifen and prevent its toxic effect.
    Ben-Hur H; Kossoy G; Zusman I
    Int J Oncol; 2002 Feb; 20(2):413-7. PubMed ID: 11788910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonism of development and growth of 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors by the antiestrogen U 23,469 and effects on estrogen and progesterone receptors.
    Tsai TL; Katzenellenbogen BS
    Cancer Res; 1977 May; 37(5):1537-43. PubMed ID: 404032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interaction of dietary fat and antiestrogen treatment on DMBA-induced mammary tumors in the rat.
    King MM; Pento JT; Magarian RA; Brueggemann G
    Nutr Cancer; 1985; 7(4):239-49. PubMed ID: 3938837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predominant role of prolactin in stimulating the growth of 7, 12-dimethylbenz(a)anthracene-induced rat mammary tumor.
    Manni A; Trujillo JE; Pearson OH
    Cancer Res; 1977 Apr; 37(4):1216-9. PubMed ID: 191182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polyamines and hormonal regulation of N-nitrosomethylurea-induced rat mammary tumor growth in vivo.
    Manni A; Wright C; Demers L; Luk G
    Cancer Res; 1986 Oct; 46(10):4938-41. PubMed ID: 3756855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of tamoxifen plus octreotide on DMBA-induced mammary tumors in rats].
    Zeng XZ; Yao ZX
    Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(1):28-32. PubMed ID: 15808071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor effect of the antiestrogen, tamoxifen, ona pregnancy-dependent mouse mammary tumor (TPDMT-4).
    Matsuzawa A; Mizuno Y; Yamamoto T
    Cancer Res; 1981 Jan; 41(1):316-24. PubMed ID: 7448771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cumulative effects of lentinan and endocrine therapy on the growth of DMBA-induced mammary tumor in rats].
    Kosaka A; Imaizumi A; Hatori Y; Mori F; Wani T; Yamashita A
    Gan To Kagaku Ryoho; 1984 Jul; 11(7):1399-407. PubMed ID: 6430243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor actions of keoxifene and tamoxifen in the N-nitrosomethylurea-induced rat mammary carcinoma model.
    Gottardis MM; Jordan VC
    Cancer Res; 1987 Aug; 47(15):4020-4. PubMed ID: 3607747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3,4-bis(3'-hydroxyphenyl)hexane--a new mammary tumor-inhibiting compound. Studies on the mechanism of action on the DMBA-induced, hormone-dependent mammary tumor of the rat.
    Hartmann RW; Schönenberger H; Wrobel KH
    J Cancer Res Clin Oncol; 1982; 103(3):241-54. PubMed ID: 6288725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypophysectomy and injections of high doses of estrogens inhibit the growth of ovary-independent rat mammary carcinomas.
    Nomura S; Yoshida H; Kaneko Y
    In Vivo; 1990; 4(2):121-5. PubMed ID: 1966585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of high dietary fat on the growth and development of ovarian-independent carcinogen-induced mammary tumors in rats.
    Sylvester PW; Ip C; Ip MM
    Cancer Res; 1986 Feb; 46(2):763-9. PubMed ID: 3079669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a new clinically relevant antiestrogen (GW5638) related to tamoxifen on breast and endometrial cancer growth in vivo.
    Dardes RC; O'Regan RM; Gajdos C; Robinson SP; Bentrem D; De Los Reyes A; Jordan VC
    Clin Cancer Res; 2002 Jun; 8(6):1995-2001. PubMed ID: 12060645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dichotomous effects of tamoxifen on a transplantable rat mammary tumor.
    Ip MM; Milholland RJ; Rosen F; Kim U
    Cancer Res; 1981 Mar; 41(3):984-8. PubMed ID: 7459886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of host hormonal status on binding of activated estrogen receptor to nuclei from R3230AC and 7,12-dimethylbenz[a]anthracene-induced mammary tumors.
    Klinge CM; Bambara RA; Zain S; Hilf R
    Cancer Res; 1989 Mar; 49(5):1165-70. PubMed ID: 2492902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of nonsteroidal antiestrogens, analog II and tamoxifen, on a metastatic transplantable rat mammary tumor.
    King MM; Magarian RA; Terao J; Brueggemann GL
    J Natl Cancer Inst; 1985 Feb; 74(2):447-51. PubMed ID: 3919197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of tamoxifen on mammary tumors and bone in 7,12-dimethylbenz-(a)anthracene-treated rats.
    Suzuki S; Kitamura S; Sakamoto S; Sassa S; Mitamura T; Kudo H; Kuwa K; Yoshimura S; Maemura M; Nakayama T; Zhou YF; Hara Y; Shinoda H; Nagasawa H
    Anticancer Res; 1998; 18(2A):871-6. PubMed ID: 9615734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor effect of pyridoglutethimide, an aromatase inhibitor, on 7,12-dimethylbenz(a)anthracene-induced mammary tumors of rat.
    Yamamoto T; Urabe M; Tamura T; Kitawaki J; Honjo H; Okada H
    Anticancer Res; 1991; 11(6):1999-2002. PubMed ID: 1776832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.